TrialThe Journal of clinical investigation2022

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.

David S Perlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.